By Ben LevisohnInvestors love biotech stocks, but heading into July, Amgen (AMGN) was unloved, especially compared to its other biotech giants like Regeneron Pharmaceuticals (REGN), Gilead Sciences (GILD) and Biogen (BIIB). No longer. Shares of Amgen have jumped nearly 6% after reporting better than forecast earnings and raising its guidance. UBS analyst Matthew Roden has the details:
Amgen reported another strong […]
By Ben LevisohnIn a note this morning, BofA Merrill Lynch’s Christina Giannini and team note that the risk for big-cap biotech stocks–think Gilead Sciences (GILD) and Biogen (BIIB)–and small-cap biotech stocks–everything else–are quite different. They explain:
Associated Press
Biotech is now more passive than actively managed: Perhaps due to the difficulty picking stocks within such an idiosyncratic sector given the complicated science […]
Janet Yellen is facing Congress on Wednesday for her semi-annual testimony.And one year ago today, Yellen’s monetary policy report warned about stock market valuations, particularly in social media and biotech stocks. It was an awful call. Yellen’s testimony last year said:”Some broad equity price indexes have increased to all-time highs in nominal terms since the end of 2013. However, valuation measures for the overall market in […]
Janet Yellen is facing Congress on Wednesday for her semi-annual testimony.And one year ago today, Yellen’s monetary policy report warned about stock market valuations, particularly in social media and biotech stocks. It was an awful call. Yellen’s testimony last year said:”Some broad equity price indexes have increased to all-time highs in nominal terms since the end of 2013. However, valuation measures for the overall market in […]
Stocks are finally breaking out!The Russell 2000 small-cap index? Check. Midcap stocks? Double check. Blistering biotechs? Triple check. In fact, The Biotech iShares continued to reach for new highs Monday after last week’s jolt.There are still some weak spots out there, like utilities. But if you’re taking the time to zero-in on the strongest stocks in the strongest sectors, you’re […]
While Thursday’s weak CPI report gave hope that inflation might stay too low for the Fed to realistically raise rates, much of the week’s equity rally had more to do with four weeks of steadily receding momentum than with the hope that rate hikes might be postponed into 2016 – even the more dovish Fed couldn’t stand in the way […]
Akin Oyedele
Jun. 18, 2015, 12:33 PM
328
ZaldyImg/FlickrBiotech stocks are having a massive Thursday.The iShares Nasdaq Biotechnology ETF rallied more than 3% on Thursday to a new all-time high.The ETF, which tracks stocks in the industry, has seen two big plunges this year, including a 10% correction in April.Despite these zigzags, the trend is up, and the industry has rallied with other […]
All eyes turn to the Fed this week as the FOMC gathers in Washington to decide whether the time has come to raise the Federal funds rate, something that hasn’t been seen in America in nearly eight years. And while September remains the odds on favorite for the first rate hike, it was only a few weeks ago that money […]
“If you want to see capitalism in action, go to Hong Kong.” ~ Milton FriedmanHong Kong has come a long way. As a British colony, it was described as a “barren rock” by former British foreign secretary and prime minister Lord Palmerston. Today, the Hong Kong Stock Exchange is the fourth-largest in the world. It will likely soon be the […]
By Ben LevisohnIt’s been a bad, bad week for biotech stocks. The iShares Nasdaq Biotech Index ETF (IBB) had dropped 9.3% this week through Thursday’s close, while Amgen (AMGN), Biogen Idec (BIIB), and Celgene (CELG) also suffered big losses. Evercore ISI’s Mark Schoenebaum notes that the valuations of big biotech companies is trading below that of the S&P 500 for only the […]
